DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ rose 1.66% to $219.07 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.49% to 7,764.70 and the Dow Jones Industrial Average rising 0.71% to 52,048.83.
Biogen Inc. closed 2.98% short of its 52-week high of $225.80, which the company achieved on September 3rd.
The stock outperformed some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.19% to $269.47, Pfizer Inc. $(PFE)$ rose 0.29% to $27.74, and AbbVie Inc. $(ABBV)$ rose 0.20% to $264.48.
Trading volume (928,545) remained 96,480 below its 50-day average volume of 1.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 21, 2026.
Comments